Immune response study for colorectal cancer
Part of Cancer, Digestive system clinical trials.
This study looks at how the immune system reacts to colorectal cancer in the body. It aims to understand immune responses better, which may help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You must have colorectal cancer (adenocarcinoma)
- You are scheduled to have surgery to remove the tumor or metastases
- You are not pregnant or breastfeeding
- You do not have HIV
- You must be able to understand the study information and follow procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment made from your own immune cells (called TILs) that are taken from your tumor, grown in a lab, and given back to you along with immunotherapy. It is for people with advanced colon or rectum cancer who have run out of standard options.
This study looks at how tumors in the digestive system interact with the body’s immune system and the surrounding environment. Results may help improve understanding of these cancers and guide future treatments.
This study collects tissue and blood samples from people with colorectal, pancreatic, or bile duct cancer to learn how the immune system reacts to these tumors. The goal is to better understand cancer biology and potentially improve future treatments.
This study looks at how gut bacteria and immune activity differ in normal, pre-cancer, and cancer colon tissue. It may help researchers understand what changes in the body are linked to colon growth and how they could be targeted in the future.
This study looks at how bacteria in your gut, your immune system, and colon cancer interact. It aims to understand these connections to improve future treatments.
This study follows people with colorectal cancer of any stage to learn more about their care and outcomes. It may help researchers improve treatments for future patients.
Hear when a new Colon Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.